Occult primary tumors of the head and neck: Detection with 2-[F-18]fluoro-2- deoxy-D-glucose SPECT

Radiology

Volumn 199, Issue 3, 1996, Pages 761-766

  Mukherji, Suresh K ^a   Drane, Walter E ^a   Mancuso, Anthony A ^a   Parsons, James T ^a   Mendenhall, William M ^a   Stringer, Scott ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Fluorine; Head and neck neoplasms, diagnosis, 20.373; Head and neck neoplasms, emission CT (ECT), 20.12162

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; BIOPSY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LARYNX TUMOR; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PHARYNX TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASMS, UNKNOWN PRIMARY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029951841     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.199.3.8638002     Document Type: Article

References (21)

1. Martin H, Morfit HM. Cervical node metastasis as the first symptom of cancer. Surg Gynecol Obstet 1944; 70:133-159.
2. MacComb WS. Diagnosis and treatment of metastatic cervical cancerous nodes from an unknown primary site. Am J Surg 1972; 124:441-449.
3. Million RR, Cassisi NJ, Mancuso AA. The unknown primary. In: Million RR, Cassisi NJ, eds. Management of head and neck cancer: a multidisciplinary approach. 2nd ed. Philadelphia, Pa: Lippincott, 1994; 311-321.
4. Harper CS, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck 1990; 12:463-469.
5. Parsons JT. The effect of radiation therapy on normal tissues of the head and neck. In: Million RR, Cassisi NJ, eds. Management of head and neck cancer: a multidisciplinary approach. 2nd ed. Philadelphia, Pa: Lippincott, 1994; 245-291.
6. Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH. Fluorodeoxyglucose PET of abdominal neoplasms: potential role in oncologic imaging. Radio-Graphics 1993; 13:1047-1062.
7. DiChiro G, Adfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR 1988; 150:189-197.
8. Rozenthal JM, Levin RL, Nickels RJ, et al. Glucose uptake by glioma after treatment: a positron emission tomographic study. Arch Neurol 1989; 46:1302-1307.
9. 82Rb positron emission tomography. J Comput Assist Tomogr 1987; 11:563-570.
10. Coleman EC, Hoffman JM, Hanson MW, Sostman HD, Schold SC. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991; 32:616-622.
11. Schwartz RB, Caravalho PA, Alexander E III, et al. Radiation necrosis vs high grade recurrent glioma: differentiation by using dual-isotope SPECT with T1-201 and Tc-99 HMPAO. AJR 1993; 158:399-405.
12. 201Thallium SPECT imaging in childhood brain tumors. Pediatr Neurosurg 1994; 20: 11-18.
13. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32:623-648.
14. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18] fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
15. Minn H, Josensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo-comparison with DNA flow cytometry in head and neck tumors. Cancer 1988; 61:1776-1781.
16. Greven KM, Williams DW, Keyes JW, et al. Positron emission tomography of patients with head and neck cancer before and after high-dose irradiation. Cancer 1994; 74:1355-1359.
17. Mukherji SK, Drane WD, Tart RP, Landau S, Mancuso AA. Comparison of thallium-201 SPECT and F-18 2-fluoro-2-deoxy-D-glucose SPECT uptake in squamous cell carcinoma of the head and neck. AJNR 1994;15:1837-1842.
18. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH. Technology for FDG SPECT with a relatively inexpensive gamma camera. Radiology 1994; 191:461-465.
19. Muraki AS, Mancuso AA, Harnsberger HR. Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. Radiology 1984; 152:749-753.
20. Laugenbacher C, Wagner-Mansku C, Saumweber D, et al. Comparison of F-18 FDG PET, MRI and endoscopy for staging of squamous cell carcinomas of the head and neck. Presented at the International Congress of Head and Neck Radiology, Washington, DC, June 1994.
21. McLaughlin MP, Mendehall WM, Mancuso AA, et al. Retro-pharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck. Head Neck 1995; 17:190-198.